Characteristics of the 103 Patients | ||||
---|---|---|---|---|
Variable | All (N=103) | Treatment experienced (n=86) | Treatment naïve (n=17) | p-value |
Demographics | ||||
Females/number (%) | 82 (80) | 71 (87) | 11 (13) | 0.095 |
Males /number (%) | 21 (20) | 15 (71) | 6 (29) | |
Age in years /median (IQR) | 39 (33-46) | 39.5 (35-46) | 36 (31-40) | 0.197 |
Clinical Characteristics | ||||
Time on ART in years /median(IQR) | 4(2-7) | |||
Time since HIV diagnosis in years /median (IQR) | 5 (3-8) | 5 (3-8) | 2 (1-4) | <0.0001 |
CD4 count/ median(IQR) | 468 (269- 658) | 491 (294- 662) | 292 (4-540) | 0.056 |
Patient Characteristics by Drug Resistance Mutations | ||||
Variable | All (N=103) |
HIVDR+ (n=6), 6% |
HIVDR- (n=97), 94% | p-value |
Age in years /median (IQR) | 39 (33-46) | 45 (32-55) | 39 (33.5-45) | 0.852 |
CD4 count cells /mm3/ median (IQR) | 468 (269-658) | 261 (127-399) | 480 (281-661) | 0.117 |
Viral load/ copies/ml / median /(IQR) | 37 (20-37) | 37 (20-45) | 37 (20-37) | 0.688 |
Time on ART in years/ median(IQR) | 3 (0.1-5) | 4 (1.5-5) | 3 (0.05-5. 5) | 0.232 |